<DOC>
	<DOCNO>NCT02098733</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy long-term use Sonias Combination Tablets patient type 2 diabetes mellitus routine clinical setting .</brief_summary>
	<brief_title>Long-term Use Sonias Combination Tablets Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>This special drug use surveillance long-term use pioglitazone/glimepiride combination tablet ( Sonias Combination Tablets ) design investigate frequency adverse drug reaction patient type 2 diabetes mellitus routine clinical setting . The usual adult dosage one tablet Sonias administer orally daily breakfast ( 15 mg/1 mg 30 mg/3 mg pioglitazone/glimepiride ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Patients type 2 diabetes mellitus physician conclude combination therapy pioglitazone hydrochloride glimepiride appropriate longterm treatment Sonias Combination Tablets consider necessary ( 1 ) Patients cardiac failure history cardiac failure ( 2 ) Patients serious hepatic renal impairment ( 3 ) Patients severe ketosis , diabetic coma precoma , type 1 diabetes mellitus ( 4 ) Patients severe infection , severe trauma , pre postoperative patient ( 5 ) Patients gastrointestinal disorder diarrhea vomit ( 6 ) Pregnant potentially pregnant woman ( 7 ) Patients history hypersensitivity ingredient Sonias Combination Tablets sulfonamide</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Pharmacological therapy</keyword>
</DOC>